These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 32076467)
21. Construction and analysis for differentially expressed long non-coding RNAs and MicroRNAs mediated competing endogenous RNA network in colon cancer. Li F; Li Q; Wu X PLoS One; 2018; 13(2):e0192494. PubMed ID: 29420609 [TBL] [Abstract][Full Text] [Related]
22. Identification of hub genes and construction of an mRNA-miRNA-lncRNA network of gastric carcinoma using integrated bioinformatics analysis. Wei G; Dong Y; He Z; Qiu H; Wu Y; Chen Y PLoS One; 2021; 16(12):e0261728. PubMed ID: 34968391 [TBL] [Abstract][Full Text] [Related]
23. Identification of Potential Biomarkers Involved in Gastric Cancer Through Integrated Analysis of Non-Coding RNA Associated Competing Endogenous RNAs Network. Xing C; Cai Z; Gong J; Zhou J; Xu J; Guo F Clin Lab; 2018 Oct; 64(10):1661-1669. PubMed ID: 30336538 [TBL] [Abstract][Full Text] [Related]
24. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer. Fan CN; Ma L; Liu N J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893 [TBL] [Abstract][Full Text] [Related]
25. Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma. Zhang Z; Qian W; Wang S; Ji D; Wang Q; Li J; Peng W; Gu J; Hu T; Ji B; Zhang Y; Wang S; Sun Y Cell Physiol Biochem; 2018; 49(5):1778-1791. PubMed ID: 30231249 [TBL] [Abstract][Full Text] [Related]
26. Identification of lncRNA-associated ceRNA network in high-grade serous ovarian cancer metastasis. Li X; Yu S; Yang R; Wang Q; Liu X; Ma M; Li Y; Wu S Epigenomics; 2020 Jul; 12(14):1175-1191. PubMed ID: 32462930 [No Abstract] [Full Text] [Related]
27. Long Non-Coding RNA HAND2-AS1 Acts as a Tumor Suppressor in High-Grade Serous Ovarian Carcinoma. Gokulnath P; de Cristofaro T; Manipur I; Di Palma T; Soriano AA; Guarracino MR; Zannini M Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517089 [TBL] [Abstract][Full Text] [Related]
28. CST2 promotes cell proliferation and regulates cell cycle by activating Wnt-β-catenin signalling pathway in serous ovarian cancer. Wang X; Zhao S; Guo Y; Wang C; Han S; Wang X J Obstet Gynaecol; 2024 Dec; 44(1):2363515. PubMed ID: 38864487 [TBL] [Abstract][Full Text] [Related]
29. Identification of functional lncRNAs in gastric cancer by integrative analysis of GEO and TCGA data. Zhang X; Zhang W; Jiang Y; Liu K; Ran L; Song F J Cell Biochem; 2019 Oct; 120(10):17898-17911. PubMed ID: 31135068 [TBL] [Abstract][Full Text] [Related]
30. Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non‑small cell lung cancer. Wang XW; Guo QQ; Wei Y; Ren KM; Zheng FS; Tang J; Zhang HY; Zhao JG Oncol Rep; 2019 Dec; 42(6):2402-2415. PubMed ID: 31638248 [TBL] [Abstract][Full Text] [Related]
31. Cox-LASSO Analysis Reveals a Ten-lncRNA Signature to Predict Outcomes in Patients with High-Grade Serous Ovarian Cancer. Xu L; Wu Y; Che X; Zhao J; Wang F; Wang P; Qu X; Liu Y; Li Z DNA Cell Biol; 2019 Dec; 38(12):1519-1528. PubMed ID: 31657627 [TBL] [Abstract][Full Text] [Related]
32. SSTR5‑AS1 functions as a ceRNA to regulate CA2 by sponging miR‑15b‑5p for the development and prognosis of HBV‑related hepatocellular carcinoma. Xu J; Zhang J; Shan F; Wen J; Wang Y Mol Med Rep; 2019 Dec; 20(6):5021-5031. PubMed ID: 31638225 [TBL] [Abstract][Full Text] [Related]
33. Integrated Analysis of mRNA-miRNA-lncRNA ceRNA Network in Human HR+/Her-2- Breast Cancer and Triple Negative Breast Cancer. Jia X; Shi Y; Zhu Y; Meng W; He L; Jia Y; Tong Z J Comput Biol; 2020 Jul; 27(7):1055-1066. PubMed ID: 31647320 [TBL] [Abstract][Full Text] [Related]
34. Long Non-coding RNA Yim GW; Kim HJ; Kim LK; Kim SW; Kim S; Nam EJ; Kim YT Cancer Res Treat; 2017 Jul; 49(3):656-668. PubMed ID: 27737536 [TBL] [Abstract][Full Text] [Related]
35. [Construction and analysis of competitive endogenous RNA regulatory network related to gastric cancer]. Li R; Jiang WJ; Jin SL; Zhao RH; Cao XG; Zong H Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):115-121. PubMed ID: 32135645 [No Abstract] [Full Text] [Related]
36. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer. Ye Y; Li SL; Wang SY PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363 [TBL] [Abstract][Full Text] [Related]
37. Comprehensive Analysis of a ceRNA Network Identifies lncR-C3orf35 Associated with Poor Prognosis in Osteosarcoma. Shi Y; Ren J; Zhuang Z; Zhang W; Wang Z; Liu Y; Li J; Liang T; He R; Wang K Biomed Res Int; 2020; 2020():3178037. PubMed ID: 33015161 [TBL] [Abstract][Full Text] [Related]
38. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs. Zhao Q; Fan C BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053 [TBL] [Abstract][Full Text] [Related]
39. Integrated analysis of long non-coding RNA‑associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma. Sui J; Li YH; Zhang YQ; Li CY; Shen X; Yao WZ; Peng H; Hong WW; Yin LH; Pu YP; Liang GY Int J Oncol; 2016 Nov; 49(5):2023-2036. PubMed ID: 27826625 [TBL] [Abstract][Full Text] [Related]
40. Prognostic value of the tumor-specific ceRNA network in epithelial ovarian cancer. Li G; Han L; Ren F; Zhang R; Qin G J Cell Physiol; 2019 Dec; 234(12):22071-22081. PubMed ID: 31152442 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]